Biologics

About the Biologics
Biologics have revolutionized treatment of moderate to severe psoriasis and psoriatic arthritis. Unlike other therapies for these conditions, the biologics are considered a potentially safer option for long-term therapy. Three of the biologics may even slow or stop the joint damage of psoriatic arthritis. Before the biologics, people with psoriatic arthritis could take medication to alleviate the symptoms, but treatment could not prevent joint damage, which can cause lifelong disability. The biologics also have proven effective for some people when other therapies have not worked.

Talking with a dermatologist who has experience with the biologics is the best way to decide if a biologic is an appropriate treatment option. Before speaking with a dermatologist, it helps to know a bit about the biologics. The U.S. Food and Drug Administration (FDA) has approved the following biologics for adults with plaque psoriasis and/or psoriatic arthritis:

An educational program brought to you by the American Academy of Dermatology.

For an overview, visit the AAD pamphlet Psoriasis and Psoriatic Arthritis.

Supported by an educational donation provided by Amgen and Wyeth.